Introduction
Pharmacy-to-pharmacy medicine exchange rules in Turkey are an important part of Turkish pharmacy law because they define when a pharmacy may transfer medicine stock to another pharmacy without violating the prohibition on wholesale medicine sales. In Turkish practice, this transaction is commonly called eczaneler arası ilaç takası, meaning medicine exchange between pharmacies.
At first glance, pharmacy-to-pharmacy exchange may look like an ordinary commercial stock transaction. In reality, it is a regulated exception. Turkish law generally prohibits pharmacies from selling medicines wholesale, but it recognizes that pharmacies may sometimes need to exchange medicines with each other for patient service, urgent supply, stock balancing or practical pharmacy operation. This exception is narrow and must be used carefully.
The current Regulation on Pharmacists and Pharmacies states that pharmacies cannot make wholesale sales of poisonous and potent substances and medicines, and cannot participate in tenders. It then expressly provides that medicine exchange between pharmacies is not considered wholesale sale; however, medicine exchange may be made only between pharmacies operating within the same province.
This rule has two essential consequences. First, lawful pharmacy-to-pharmacy exchange is possible. Second, it is not unlimited. A pharmacy cannot use exchange as a disguised wholesale business, cannot create interprovincial medicine distribution networks and cannot transfer medicine stock to unauthorized persons, companies, clinics, warehouses or non-pharmacy sellers.
For pharmacists, the practical question is not simply “Can I give medicine to another pharmacy?” The correct legal question is: Is this transaction a lawful pharmacy-to-pharmacy exchange within the same province, properly documented, correctly notified through İTS, compatible with stock records, and not a disguised wholesale sale?
Legal Framework of Pharmacy-to-Pharmacy Exchange
The main legal sources are Law No. 6197 on Pharmacists and Pharmacies and the Regulation on Pharmacists and Pharmacies. Law No. 6197 defines pharmacy as a healthcare service and states that opening and operating a pharmacy requires being a pharmacist. It describes pharmacy as a professional healthcare activity involving medicine preparation and supply, monitoring of medicine safety and efficacy, quality assurance, patient information and reporting of medicine-related problems.
The Regulation on Pharmacists and Pharmacies regulates pharmacy opening, operation, relocation, transfer, closure, pharmacy characteristics and pharmacy services. It applies to pharmacies opened or to be opened under Law No. 6197 and to pharmacy services and pharmacists.
Within this framework, pharmacy-to-pharmacy medicine exchange is regulated as an exception to the wholesale sale prohibition. The Regulation provides that pharmacies cannot sell medicines wholesale, but medicine exchange between pharmacies is not considered wholesale sale if it is made between pharmacies operating within the same province.
Another key provision is Article 27 of the Regulation. This article requires pharmacies to use the medicine tracking system for purchases, sales, returns to the warehouse from which medicines were obtained, returns to other warehouses in force majeure or pharmacy closure situations, pharmacy-to-pharmacy exchanges and destruction of expired or deteriorated medicines. It also requires notification to the system.
Therefore, lawful exchange has at least three legal pillars: it must be between pharmacies, it must be within the same province, and it must be recorded through the İlaç Takip Sistemi, known as İTS.
What Is Pharmacy-to-Pharmacy Medicine Exchange?
Pharmacy-to-pharmacy medicine exchange is the lawful transfer of a medicine from one licensed pharmacy to another licensed pharmacy under the conditions permitted by pharmacy legislation. It is not the same as wholesale sale, commercial distribution, supplier activity, warehouse operation or medicine trading by non-pharmacy entities.
In practice, exchange may occur where one pharmacy urgently needs a medicine for a patient and another nearby pharmacy has it in stock. It may also occur where a pharmacy has excess stock of a medicine while another pharmacy needs that medicine. The legal purpose is to support continuity of pharmacy service and patient access, not to create an alternative medicine distribution market.
The exchange must remain exceptional, traceable and pharmacy-centered. If a pharmacy regularly transfers large volumes of medicines to many other pharmacies, earns systematic profit from such transfers, operates like a supplier or sends medicines outside the province, the transaction may lose its character as lawful exchange and may be evaluated as disguised wholesale sale.
Difference Between Exchange and Wholesale Sale
The distinction between exchange and wholesale sale is crucial. The Regulation expressly states that medicine exchange between pharmacies is not considered wholesale sale, but this sentence should not be read as a blanket permission for pharmacies to trade medicines freely. The same provision also states that pharmacies cannot sell medicines wholesale and cannot participate in tenders.
A lawful exchange is usually limited, pharmacy-to-pharmacy, patient-service-oriented and traceable. Wholesale sale, by contrast, involves systematic commercial distribution, stock movement for resale, large-volume transactions, repeated supply activity, tender participation or acting as a de facto pharmaceutical warehouse.
A pharmacy should therefore evaluate each exchange transaction carefully. If the transaction looks like ordinary pharmacy cooperation, it is more likely to be defensible. If it looks like a business model, it is risky. The safest approach is to use exchange only for legitimate pharmacy needs and to document the reason, parties, product, quantity and İTS notification.
Same-Province Requirement
One of the clearest rules is the same-province requirement. The Regulation states that medicine exchange may be made only between pharmacies operating within the same province.
This rule is strict. A pharmacy in Istanbul should not make a pharmacy-to-pharmacy exchange with a pharmacy in Ankara, Izmir, Bursa or another province. Even if both pharmacies are licensed, the transaction falls outside the legal wording if they do not operate in the same province.
The purpose of the same-province limitation is to prevent exchange from becoming nationwide distribution. If interprovincial transfers were allowed freely, pharmacies could create unofficial supply chains and bypass pharmaceutical warehouses, medicine tracking controls and public health supervision.
For pharmacists, this means that before making an exchange, the pharmacy should verify the recipient pharmacy’s province. The transaction should be documented in a way that shows both pharmacies operate within the same province. This is especially important in metropolitan regions where districts may be close but provincial boundaries matter.
Exchange Must Be Between Licensed Pharmacies
A lawful exchange must occur between pharmacies. It cannot be made with clinics, hospitals, physicians, medical tourism agencies, nursing homes, cosmetic centers, e-commerce sellers, warehouses, companies, couriers or individual patients outside prescription supply rules.
This point is important because some actors may ask pharmacies to “exchange” or “transfer” medicines informally. If the receiving party is not a licensed pharmacy operating in the same province, the transaction should not be treated as pharmacy-to-pharmacy exchange.
The pharmacist should also avoid transfers to pharmacy employees, relatives, non-pharmacist investors or other persons who claim they will take the product to another pharmacy. The proper transaction must be between the pharmacies and must be reflected in the official medicine tracking system.
İTS Notification Requirement
The İlaç Takip Sistemi, or İTS, is the backbone of pharmacy-to-pharmacy exchange compliance. Article 27 of the Regulation requires pharmacies to use the medicine tracking system and make notifications for pharmacy-to-pharmacy exchanges.
This means a physical exchange without İTS notification is legally risky. A pharmacy cannot simply give a medicine package to another pharmacy and later rely on oral explanation. The stock movement must be traceable electronically.
İTS notification protects the transferring pharmacy, the receiving pharmacy, the patient and the public authority. It shows where the medicine moved, which pharmacy transferred it, which pharmacy received it, and whether the product remains within the lawful supply chain.
After every exchange, both pharmacies should verify that the İTS record accurately reflects the transaction. If the product leaves physical stock but remains in the transferring pharmacy’s electronic stock, a discrepancy arises. If the receiving pharmacy physically receives the product but İTS does not show lawful receipt, later sale or SGK processing may become problematic.
Consistency Between İTS, Invoice and Transaction Documents
Article 27 of the Regulation also emphasizes that the buyer shown in İTS sale, return or exchange notification must be the same as the buyer stated in the transaction documents. This rule is critical because electronic records and physical-commercial documents must match.
In pharmacy-to-pharmacy exchange, the recipient pharmacy shown in İTS should be the same pharmacy shown in any exchange document, invoice, delivery note, internal record or accounting document. A mismatch may create serious inspection questions.
For example, if İTS shows one pharmacy as the recipient but the document names another pharmacy or an individual, the transaction may appear irregular. Similarly, if a product is recorded as exchanged but accounting records show a sale to a non-pharmacy entity, this may undermine the defense that the transaction was lawful exchange.
Pharmacies should therefore keep exchange documents organized and consistent. The product name, quantity, barcode, batch or serial information, date, transferring pharmacy, receiving pharmacy and İTS reference should match across records.
Documentation of Pharmacy-to-Pharmacy Exchange
Although İTS notification is mandatory, it should not be the only record. Pharmacies should also preserve practical supporting documents. These may include exchange forms, delivery notes, internal stock movement records, accounting documents, pharmacist signatures, transaction date and reason for exchange.
A strong exchange file should answer the following questions:
Which pharmacy transferred the medicine?
Which pharmacy received it?
Are both pharmacies in the same province?
What medicine was transferred?
How many packages were transferred?
What was the barcode or product identifier?
What was the expiry date?
Was the product cold-chain or controlled?
Was İTS notification made?
Was the receiving pharmacy correctly shown?
Was the transaction linked to patient need or stock balancing?
Good documentation protects the pharmacy during inspection, SGK audit, stock reconciliation, tax review and possible disciplinary inquiry.
Patient Access and Emergency Supply Rationale
A legitimate reason for pharmacy-to-pharmacy exchange is patient access. Sometimes a patient needs a medicine urgently, and the pharmacy does not have the product in stock. Instead of forcing the patient to wait or search repeatedly, the pharmacy may obtain the product from another same-province pharmacy through lawful exchange.
This kind of exchange supports public health. It is consistent with the pharmacy’s healthcare role. However, even emergency or patient-centered exchange must comply with legal requirements. Same-province rule, İTS notification and documentation still apply.
The pharmacy should not use “patient need” as a vague justification for repeated undocumented stock transfers. If exchange is frequent, the pharmacy should monitor why it is happening. Frequent urgent exchange may indicate poor stock planning or a hidden commercial relationship.
Stock Balancing and Near-Expiry Products
Pharmacies may sometimes exchange medicines to balance stock. One pharmacy may have excess stock of a medicine, while another pharmacy needs it. This can be lawful if the exchange remains within the regulatory framework.
However, special caution is required for near-expiry products. A pharmacy should not transfer products close to expiry without informing the receiving pharmacy. If the medicine later expires, disputes may arise. The expiry date should be checked before exchange and documented.
Expired or deteriorated products must never be exchanged as usable medicine. The Regulation requires pharmacies to use İTS for destruction of expired or deteriorated medicines and to notify the system. Expired medicine management is a separate procedure, not an exchange opportunity.
Cold-Chain Medicines in Pharmacy-to-Pharmacy Exchange
Cold-chain medicines require enhanced caution during exchange. A product that must be stored under refrigeration cannot be moved casually between pharmacies without protecting temperature conditions. If cold-chain conditions are broken during transfer, the medicine may become unusable even if its expiry date has not passed.
Before exchanging a cold-chain medicine, both pharmacies should ensure proper packaging, transfer time, temperature protection and documentation. If available, cold-chain indicators or temperature monitoring should be used. The receiving pharmacy should place the medicine in proper storage immediately.
If a cold-chain product is exchanged without proper temperature control and later supplied to a patient, the pharmacist may face civil, administrative and professional liability if harm occurs or effectiveness is compromised. Therefore, cold-chain exchange should be limited to situations where safe transport can be ensured.
Controlled Medicines and Pharmacy-to-Pharmacy Exchange
Controlled medicines, narcotic medicines, psychotropic medicines and medicines subject to red or green prescription rules require strict handling. Even if pharmacy-to-pharmacy exchange is generally recognized, controlled products should not be exchanged casually.
A pharmacist should verify whether the specific controlled medicine can be lawfully exchanged and what additional records or authority notifications may be required. Physical stock, special prescription records, colored prescription system records, İTS records and pharmacy documents must remain consistent.
A discrepancy involving controlled medicine stock can have serious consequences. It may trigger inspection findings, professional disciplinary proceedings, SGK review or criminal-law scrutiny depending on the circumstances.
For this reason, many pharmacies should adopt an internal rule that controlled medicine exchange requires direct responsible pharmacist approval and enhanced documentation.
SGK and MEDULA Risks
Pharmacy-to-pharmacy exchange may indirectly affect SGK reimbursement. If a pharmacy receives a medicine through exchange and then dispenses it under an SGK-covered prescription, it must ensure that the product is lawfully in its stock and properly recorded through İTS.
SGK audits may compare prescription records, MEDULA entries, İTS stock, invoices and pharmacy documents. If the pharmacy cannot show lawful acquisition of the medicine, reimbursement problems may arise. This is especially important for high-cost medicines, report-dependent medicines, biological products, oncology medicines and chronic disease medicines.
The pharmacy should therefore preserve exchange documentation for SGK-covered medicines. The fact that the medicine was obtained from another pharmacy does not remove the pharmacy’s duty to prove lawful stock and reimbursement compliance.
Tax and Accounting Issues
Pharmacy-to-pharmacy exchange may also have accounting and tax consequences. Even if the transaction is not legally considered wholesale sale under pharmacy law, it may still require proper financial documentation. Stock leaving one pharmacy and entering another must be reflected in accounting records consistently.
The transferring pharmacy should not treat exchanged medicines as unexplained inventory loss. The receiving pharmacy should not treat them as undocumented stock. Both sides should coordinate with accountants to ensure that exchange documents, İTS records and accounting entries match.
If tax records show repeated sales that look like commercial distribution, but the pharmacy claims they are exchanges, the inconsistency may create legal risk. A pharmacy-to-pharmacy exchange system should therefore be transparent and properly documented.
Exchange and Pharmacy Closure
Article 27 refers to returns to other warehouses in cases of force majeure or pharmacy closure, and also separately refers to pharmacy-to-pharmacy exchange. During closure, a pharmacy must handle remaining stock lawfully. Some medicines may be returned to warehouses, some may be destroyed if expired or deteriorated, and some may be processed according to applicable rules.
A closing pharmacy should not use pharmacy-to-pharmacy exchange to transfer large stock in a way that resembles wholesale liquidation. If stock liquidation is necessary, the pharmacist should consult the provincial health directorate, professional chamber and accountant to determine the correct legal route.
During closure, the risk of stock irregularity increases. Physical stock, İTS, destruction records, return documents and accounting records must be reconciled before license cancellation.
Exchange and Pharmacy Transfer
A pharmacy transfer is different from pharmacy-to-pharmacy exchange. In a pharmacy transfer, the business itself is transferred to another pharmacist through official procedure. In pharmacy-to-pharmacy exchange, specific medicine packages are transferred between two operating pharmacies.
These should not be confused. If the parties are actually transferring the entire pharmacy stock as part of a sale, the transaction should be structured as pharmacy transfer or stock transfer within the legally required framework, not disguised as ordinary exchange.
The Regulation on Pharmacists and Pharmacies and Law No. 6197 regulate pharmacy transfer separately from daily medicine exchange. A pharmacist should avoid using exchange records to hide a pharmacy transfer, hidden ownership arrangement or unlicensed distribution.
Exchange and Sham Ownership Risk
Repeated exchange between pharmacies may sometimes raise muvazaa, or sham ownership, concerns. For example, if several pharmacies appear separate but constantly exchange stock under the control of one investor, one company or one pharmacist, authorities may question whether the pharmacies are genuinely independent.
Turkish pharmacy law requires genuine pharmacist ownership and personal professional responsibility. Law No. 6197 states that opening and operating a pharmacy requires being a pharmacist. If exchange transactions show that another person controls stock, purchasing or distribution among pharmacies, the issue may go beyond exchange compliance and become a sham ownership investigation.
Pharmacies should therefore ensure that exchange does not become a method for one hidden business group to manage multiple pharmacies as a network. Each pharmacy must retain independent pharmacist control.
Exchange and Prescription Referral Risk
Pharmacy-to-pharmacy exchange should not be connected to prescription steering. A pharmacy may not use exchange arrangements to direct patients or prescriptions unlawfully. For example, if one pharmacy collects prescriptions from a clinic and then obtains medicines from other pharmacies through exchange, the transaction may raise both exchange and prescription referral issues.
The Regulation prohibits prescriptions or medicine requests sent through internet, fax, phone, courier, commission agents or similar methods, except for legally valid electronic prescriptions and certain permitted prescription groups. It also prohibits open or hidden cooperation with institutions, physicians, healthcare organizations or third parties for prescription direction.
Therefore, pharmacy-to-pharmacy exchange must remain a stock movement between pharmacies, not part of a prescription collection system involving clinics, couriers, hospitals or intermediaries.
Inspection Risks
Pharmacies are subject to inspection, and pharmacy-to-pharmacy exchange records may be reviewed. Inspectors may compare physical stock, İTS records, exchange documents, invoices, SGK prescriptions, expired stock and accounting records.
Inspection risk increases where exchanges are frequent, high-value, interprovincial, poorly documented, inconsistent with İTS, involving controlled medicines, involving near-expiry products or connected to unusual prescription patterns.
A pharmacy should be ready to explain each exchange. If the pharmacist cannot explain why a product was transferred, to whom it was transferred, whether İTS notification was made or whether both pharmacies were in the same province, the transaction may be questioned.
Administrative Sanctions and Legal Consequences
Violating pharmacy-to-pharmacy exchange rules may lead to administrative findings, warnings, correction orders, product-related measures, professional disciplinary proceedings, SGK reimbursement issues, tax review and, in serious cases, license-related consequences.
The exact sanction depends on the nature of the violation. A minor documentation error may be treated differently from systematic interprovincial medicine distribution, disguised wholesale sale, controlled medicine irregularity or false İTS notification.
If the pharmacy uses exchange as a hidden wholesale business, the risk becomes serious because the Regulation expressly prohibits wholesale medicine sales by pharmacies. If the transaction is outside the same province, it violates the express same-province limitation. If İTS notification is missing, it violates Article 27’s tracking requirement.
Civil Liability
Civil liability may arise if a patient is harmed because of a medicine exchanged improperly between pharmacies. For example, if a cold-chain product is transferred without temperature control and becomes ineffective, or if a near-expiry or deteriorated medicine is exchanged and later supplied, the patient may claim damages.
Liability may involve the transferring pharmacy, receiving pharmacy or both, depending on the facts. The transferring pharmacy may be responsible if it knowingly transferred unsuitable stock. The receiving pharmacy may be responsible if it failed to check the product before dispensing. Documentation, temperature records, product condition and patient counseling may become important evidence.
Criminal Law Risks
Most exchange violations are administrative or professional in nature. However, criminal risk may arise in serious cases involving controlled medicines, counterfeit products, false records, forged prescriptions, illegal distribution, SGK fraud or patient harm.
For example, if a pharmacy uses “exchange” as a cover for supplying controlled medicines outside lawful prescription channels, the issue may move beyond ordinary pharmacy law. Similarly, false İTS records or fictitious transactions may create broader legal exposure.
A pharmacist facing such allegations should preserve all records and obtain legal assistance before giving statements.
Practical Compliance Checklist for Pharmacy-to-Pharmacy Exchange
A legally careful pharmacy should apply the following checklist before every exchange:
Confirm that the receiving party is a licensed pharmacy.
Confirm that both pharmacies operate within the same province.
Check that the product is saleable, not expired, not deteriorated and not recalled.
Check whether the product is cold-chain, controlled or high-risk.
Obtain responsible pharmacist approval for high-risk products.
Prepare an exchange document showing product, quantity, date and parties.
Make the required İTS notification.
Ensure that İTS recipient data matches transaction documents.
Preserve supporting documents.
Update internal stock records.
Coordinate accounting treatment.
Avoid repeated or large-volume exchange patterns that resemble wholesale sale.
Do not use exchange for interprovincial transfer.
Do not connect exchange to prescription referral or courier collection.
Keep all records inspection-ready.
This checklist should be part of the pharmacy’s written compliance procedure.
Common Mistakes in Pharmacy-to-Pharmacy Exchange
The first common mistake is exchanging medicines with pharmacies in another province. The Regulation permits exchange only between pharmacies operating in the same province.
The second mistake is failing to make İTS notification. Article 27 requires İTS use and notification for pharmacy-to-pharmacy exchanges.
The third mistake is treating exchange as ordinary wholesale trade. Pharmacies cannot sell medicines wholesale, and exchange is only a limited exception.
The fourth mistake is poor documentation. Without documents, the pharmacy may struggle to prove that the transaction was lawful.
The fifth mistake is exchanging near-expiry, cold-chain or controlled medicines without special precautions.
The sixth mistake is using exchange to support hidden pharmacy networks, sham ownership or prescription steering.
The seventh mistake is failing to reconcile physical stock, İTS records, invoices and accounting records.
Frequently Asked Questions
Is pharmacy-to-pharmacy medicine exchange allowed in Turkey?
Yes. The Regulation on Pharmacists and Pharmacies states that medicine exchange between pharmacies is not considered wholesale sale. However, it may be made only between pharmacies operating within the same province.
Can pharmacies exchange medicines across different provinces?
No. The Regulation expressly limits medicine exchange to pharmacies operating within the same province.
Is İTS notification required for pharmacy-to-pharmacy exchange?
Yes. Article 27 of the Regulation requires pharmacies to use the medicine tracking system and make notifications for pharmacy-to-pharmacy medicine exchange.
Is pharmacy-to-pharmacy exchange the same as wholesale sale?
No. The Regulation states that pharmacy-to-pharmacy medicine exchange is not considered wholesale sale. However, pharmacies are prohibited from making wholesale medicine sales, so exchange cannot be used as disguised wholesale activity.
Can cold-chain medicines be exchanged between pharmacies?
Cold-chain medicines require special caution. Any exchange must preserve storage conditions, protect the cold chain, be properly documented and be notified through İTS. If cold-chain conditions cannot be protected, the product should not be exchanged.
Can expired medicines be exchanged?
No. Expired or deteriorated medicines should not be exchanged as saleable products. Article 27 requires İTS notification for destruction of expired or deteriorated medicines.
Conclusion
Pharmacy-to-pharmacy medicine exchange rules in Turkey create a limited and regulated exception to the prohibition on wholesale medicine sales by pharmacies. Turkish law recognizes that pharmacies may need to exchange medicines for legitimate pharmacy service reasons, but it does not allow pharmacies to become informal wholesalers or distribution centers.
The key rule is clear: pharmacy-to-pharmacy medicine exchange is not considered wholesale sale, but it may be made only between pharmacies operating within the same province. Pharmacies cannot sell medicines wholesale and cannot use exchange to bypass this prohibition.
The second key rule is traceability. Article 27 of the Regulation requires İTS notification for pharmacy-to-pharmacy exchange. The electronic record, transaction documents, stock movement and accounting records must be consistent.
For pharmacists, the safest approach is preventive compliance. Every exchange should be limited, justified, same-province, pharmacy-to-pharmacy, properly documented, notified through İTS and consistent with stock records. Special caution is required for cold-chain medicines, controlled medicines, high-cost medicines, SGK-covered products and near-expiry stock.
Pharmacies should avoid repeated, high-volume or interprovincial exchange patterns that may look like wholesale trade. They should also avoid using exchange in connection with prescription referral, courier collection, hidden investor networks or sham ownership structures.
In Turkey, pharmacy-to-pharmacy medicine exchange can support patient access and practical pharmacy service, but only if it stays within the boundaries of Turkish pharmacy law. A legally compliant exchange system protects patients, pharmacists, medicine traceability, SGK integrity and the professional independence of pharmacies.
Yanıt yok